IL4 and secondary progressive multiple sclerosis: The study authored by Windhagen et al. also found that patients with SPMS, in the presence of IL-12 or anti-IL-4 antibodies, tended to have fewer IL-4-secreting T cells compared to controls or patients with the RRMS form [58].